ABSC Pure Organic CBD Oil™ For Dogs Used in More Clinical Trials
Aided in large part by the commitment and investment of science-driven firms like ABSC Organics, cannabis research for veterinary patients is cautiously advancing. Dr. Stephanie McGrath, a neurologist and assistant professor at Colorado State University’s College of Veterinary Medicine & Biomedical Sciences, is on the forefront of veterinary cannabidiol research. She has completed two recent clinical studies on the effects of cannabidiol in dogs with epilepsy or osteoarthritis. This work was recently published in The Journal of the American Veterinary Association:
“An initial investigation involving 30 healthy research animals found that CBD was tolerated and resulted in measurable blood concentrations. Dr. McGrath expects results of that study will be published this year. Data from the other studies are being analyzed, but preliminary results of the epilepsy investigation were promising enough that, in January, Dr. McGrath began a three-year crossover study of CBD for epilepsy in dogs with a $350,000 grant from the American Kennel Club.”
ABSC Organics is a Proud Partner in Advancing the Field of Veterinary CBD Research
ABSC Organics provided the funding and CBD oil for Dr. McGrath’s study. We are deeply committed to raising the bar for research and analysis in this arena, and we are proud to partner with the scientists who are leading the push for better data and rigorous clinical analysis.